Market Overview

According to the fortune business insights, the Europe dietary supplements market size was valued at USD 26.60 billion in 2024. The market is projected to grow from USD 28.74 billion in 2025 to USD 50.69 billion by 2032, exhibiting a CAGR of 8.45% during the forecast period.

The analysis shows that market growth is driven by a rapidly increasing geriatric population, a growing focus on preventive healthcare, and strong consumer demand for natural, vegan, and clean-label supplements. The COVID-19 pandemic further accelerated these trends, boosting the demand for immunity-supporting products as consumers adopted a more proactive approach to their health.

Major Players Profiled in the Market Report:

• Abbott Laboratories (U.S.)
• Amway Corporation (U.S.)
• Archer Daniels Midland Company (U.S.)
• GlaxoSmithKline plc (U.K.)
• Glanbia Nutritionals (U.S.)
• Herbalife Nutrition Ltd. (U.S.)
• Nestle S.A. (Switzerland)
• Danone S.A. (France)
• Pfizer Inc. (U.S.)
• Suntory Holdings Ltd. (Japan)
• Bayer AG (Germany)

Segments

Surging Demand for Wellness to Propel Vitamin Segment Growth

Based on type, the market is divided into vitamins, minerals, enzymes, fatty acids, proteins, and others. The vitamins segment holds the dominant market share, driven by heightened consumer awareness of vitamin deficiencies and a strong focus on boosting physical and mental health.

Convenience and Precise Dosage to Drive Capsules Segment Expansion

By form, the market is categorized into tablets, capsules, liquid, and powder. The capsules segment leads the market due to its high convenience, affordability, and ability to provide a precise, defined dosage, making it a preferred choice for both manufacturers and consumers.